维普期刊资源整合服务平台（V6.5）

83篇 您的检索式：作者名="LODISE TP"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia显示文摘	Lodise TP Mckinnon PS Swiderski L	2003	Clin Infect Dis2003，36，：	1
2	Management of meningitis due to antibiotic-resistant Acinetobacter species显示文摘	Kim BN Pe\|eg AY Lodise TP	2009	Lancet Infect Dis2009，9，4：	1
3	Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on 13-lactam antibiotics 显示文摘	Lodise TP Lomaestro BM Drusano GL	2006	Phannacotherapy2006，26，9：	1
4	Pharmaeodynamic profiling of piperacillin in the prsence of tazobaetam in patients through the use of population phanmcokinetic modds and monte carlo simulation 显示文摘	Lodise Jr TP Lomaestm B Rodvold KA	2004	Antimicvob Agents Chemother2004，48，12：	1
5	Application d antimicrobial phannacodynamic concepts into dinical practice: foucus on beta-lactam antibiotics: insights from the society of infectious diseases phamutcists 显示文摘	Lodise TP Lomaestro BM Drusano GL	2006	Pharmacotherapy2006，26，9：	1
6	Ceftaroline fosamil in the treatment of community- acquired bacterial pneumonia and acute bacterial skin and skin struc- ture infections 显示文摘	Lodise TP Low DE	2012	Drugs2012，72，11：	1
7	Man- agement of meningitis due to antibiotic-re- sistant Acinetobacter species 显示文摘	Kim BN Peleg AY Lodise TP	2009	The Lancet infectious diseases2009，9，4：	1
8	Piperacillin-tazobactam for Pseudomonas aeruginosa infection:clinical implications of an extended-infusion dosing strategy显示文摘	Lodise TP Jr Lomaestro B Drusano GL	2007	Clin Infect Dis2007，44，3：	1
9	Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy 显示文摘	Lodise TP Lomaestro B Drusano GL	2007	Clin Infect Dis2007，44，3：	1
10	Larger vancomycin doses are associated with an increased incidence of nephrotox- ticity显示文摘	Lodise TP Lomaestro B Graves J	2008	Antimicrob Agents Chemother2008，52，7：	1
11	Epidemiology, Treat- ment, and Outcomes of Nosocomial Bacteremic Staphylococcus au- reus Pneumonia显示文摘	DeRyke CA LOdise TP Rybak MJ	2005	Chest2005，128，14：	1
12	Piperacillin - tazobactam for pseudomonas aeruginosa infection : clinic implications of an extended - infusion dosing stratigy 显示文摘	Lodise TP Lomaestro B Drusano GL	2007	Clin Infect Dis2007，44，：	1
13	Steady-state plasma pharmacokinetics of oral voriconazole in obese adults显示文摘	PAI MP LODISE TP	2011	Antimicrob Agents Chemother2011，55，6：	1
14	Clinical prediction tool toidentify patients with Pseudomonas aeruginosa respiratory tractinfections at greatest risk for multidrug resistance显示文摘	Lodise TP Miller CD Graves J	2007	AntimicrobAgents Chemother2007，51，2：	1
15	doses (at least four grams per day) are increased incidence of nephrotoxicity 显示文摘	Lodise TP Lomaestro B Graves J	2008	Chemother2008，52，：	1
16	Application of antimicrobial pharmacodynamic concepts into clinical practice:focus on beta-lactam antibiotics:insights from the Society of Infectious Diseases Pharmacists显示文摘	Lodise TP Lomaestro BM Drusano GL		0，，：	1
17	Piperacillintazobactam for Pseudomonas aeruginosa infection- Clinical im-plications of an extended-infusion dosing strategy 显示文摘	Lodise TP Jr Lomaestro B Drusano GL	2007	Clin In-fect Dis2007，44，：	1
18	The utility of acute physiology and chronic health evaluation II scores for prediction of mortality among intensive care unit(ICU)and Non-ICU patients with methicillin-resistant Staphylococcus aureus bacteremia显示文摘	Stevens V Lodise TP Tsuji B	2012	Infection control and hospital epidemiology2012，33，6：	1
19	Management of meningitis due to antibiotic-resistant acinetobacter species显示文摘	Kim BN Peleg AY Lodise TP	2009	Lancet Infect Dis2009，9，4：	1
20	Individualization of pip- eracillin dosing for critically ill patients:dosing software to optimize antimicrobial therapy 显示文摘	Felton TW Roberts JA Lodise TP	2014	Antimicrob Agents Chemother2014，58，7：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示